Ogino S, Nowak JA, Hamada T, Milner DA, Nishihara R. Insights into Pathogenic Interactions Among Environment, Host, and Tumor at the Crossroads of Molecular Pathology and Epidemiology. Annu Rev Pathol. 2019;14:83-103. doi:10.1146/annurev-pathmechdis-012418-012818
Landry LG, Ali N, Williams DR, Rehm HL, Bonham VL. Lack Of Diversity In Genomic Databases Is A Barrier To Translating Precision Medicine Research Into Practice. Health Aff (Millwood). 2018;37(5):780-785. doi:10.1377/hlthaff.2017.1595
Borriello F, van Haren SD, Levy O. First International Precision Vaccines Conference: Multidisciplinary Approaches to Next-Generation Vaccines. mSphere. 2018;3(4). doi:10.1128/mSphere.00214-18
Ogino S, Giannakis M. Immunoscore for (colorectal) cancer precision medicine. Lancet. 2018;391(10135):2084-2086. doi:10.1016/S0140-6736(18)30953-X
Doan M, Vorobjev I, Rees P, et al. Diagnostic Potential of Imaging Flow Cytometry. Trends Biotechnol. 2018;36(7):649-652. doi:10.1016/j.tibtech.2017.12.008
O’Day E, Hosta-Rigau L, Oyarzún DA, et al. Are We There Yet? How and When Specific Biotechnologies Will Improve Human Health. Biotechnol J. 2019;14(1):e1800195. doi:10.1002/biot.201800195
Ichikawa H, Nagahashi M, Shimada Y, et al. Actionable gene-based classification toward precision medicine in gastric cancer. Genome Med. 2017;9(1):93. doi:10.1186/s13073-017-0484-3
Alvarez MJ, Subramaniam PS, Tang LH, et al. A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors. Nat Genet. 2018;50(7):979-989. doi:10.1038/s41588-018-0138-4
Rehm HL. Evolving health care through personal genomics. Nat Rev Genet. 2017;18(4):259-267. doi:10.1038/nrg.2016.162
Hahn WC. A CRISPR Way to Identify Cancer Targets. N Engl J Med. 2019;380(25):2475-2477. doi:10.1056/NEJMcibr1905048